Loading…

Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers

Saved in:
Bibliographic Details
Published in:Journal of clinical pharmacology 2012-04, Vol.52 (4), p.600-606
Main Authors: Lofwall, M. R., Moody, D. E., Fang, W. B., Nuzzo, P. A., Walsh, S. L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c6166-64a464b7119b78886b63cb2742c543c686b0eb9d669d8d2c680254776abcec173
cites cdi_FETCH-LOGICAL-c6166-64a464b7119b78886b63cb2742c543c686b0eb9d669d8d2c680254776abcec173
container_end_page 606
container_issue 4
container_start_page 600
container_title Journal of clinical pharmacology
container_volume 52
creator Lofwall, M. R.
Moody, D. E.
Fang, W. B.
Nuzzo, P. A.
Walsh, S. L.
description
doi_str_mv 10.1177/0091270011401620
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4006196</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0091270011401620</sage_id><sourcerecordid>3787323661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6166-64a464b7119b78886b63cb2742c543c686b0eb9d669d8d2c680254776abcec173</originalsourceid><addsrcrecordid>eNqFUc9v0zAUjhCIlcGdE4rEOezZcZ6TC9JUsV-a1h5AO1qO4y5eU7vYSbf-9zhKqQYS4mJL_n687_lLko8EvhDC-RlARSgHIIQBQQqvkhkpCpoxBPY6mY1wNuInybsQHiMPWUHeJieUIAEK-SzZLVvpN1K5tbG6NyqkbpVe295LK4Ps0rkfQqubdPG8nzvbG5tK20yEnbZuCCOiXOOsTiN452yjtzoetk-XXgflzbY3zqaLrXGmSc_rIWgf3idvVrIL-sPhPk1-XHz7Pr_KbheX1_Pz20whQcyQSYas5oRUNS_LEmvMVU05o6pgucL4ALquGsSqKRsaH4AWjHOUtdKK8Pw0-Tr5bod6oxulx-Cd2HqzkX4vnDTiT8SaVjy4nWAASCqMBp8PBt79HHToxaMbvI2ZBeGAnFBW5pEFE0t5F4LXq-MEAmJsSvzdVJR8epnsKPhdTSSwifDkuj5-2bobnrQXrZZd30Y_ABb9MgqEQkwLGYz9RhkeZKbT-__mEDfz5VVRwBgom4RBPugXW_57gQPfhF4_HwdJvxbIc16I-7tLUSFUF_eIosx_AU8ZylY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706712483</pqid></control><display><type>article</type><title>Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers</title><source>Wiley</source><creator>Lofwall, M. R. ; Moody, D. E. ; Fang, W. B. ; Nuzzo, P. A. ; Walsh, S. L.</creator><creatorcontrib>Lofwall, M. R. ; Moody, D. E. ; Fang, W. B. ; Nuzzo, P. A. ; Walsh, S. L.</creatorcontrib><identifier>ISSN: 0091-2700</identifier><identifier>EISSN: 1552-4604</identifier><identifier>DOI: 10.1177/0091270011401620</identifier><identifier>PMID: 21610203</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Administration, Intranasal ; Adult ; Biological Availability ; Double-Blind Method ; Female ; Humans ; Injections, Intravenous ; Male ; Narcotics - administration &amp; dosage ; Narcotics - pharmacokinetics ; Opioid-Related Disorders - epidemiology ; Oxycodone - administration &amp; dosage ; Oxycodone - pharmacokinetics ; Tablets ; Young Adult</subject><ispartof>Journal of clinical pharmacology, 2012-04, Vol.52 (4), p.600-606</ispartof><rights>2012 The Author(s)</rights><rights>2012 American College of Clinical Pharmacology</rights><rights>2012 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6166-64a464b7119b78886b63cb2742c543c686b0eb9d669d8d2c680254776abcec173</citedby><cites>FETCH-LOGICAL-c6166-64a464b7119b78886b63cb2742c543c686b0eb9d669d8d2c680254776abcec173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1177%2F0091270011401620$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1177%2F0091270011401620$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,315,786,790,891,27957,27958,50923,51032</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21610203$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lofwall, M. R.</creatorcontrib><creatorcontrib>Moody, D. E.</creatorcontrib><creatorcontrib>Fang, W. B.</creatorcontrib><creatorcontrib>Nuzzo, P. A.</creatorcontrib><creatorcontrib>Walsh, S. L.</creatorcontrib><title>Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers</title><title>Journal of clinical pharmacology</title><addtitle>J Clin Pharmacol</addtitle><subject>Administration, Intranasal</subject><subject>Adult</subject><subject>Biological Availability</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Humans</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Narcotics - administration &amp; dosage</subject><subject>Narcotics - pharmacokinetics</subject><subject>Opioid-Related Disorders - epidemiology</subject><subject>Oxycodone - administration &amp; dosage</subject><subject>Oxycodone - pharmacokinetics</subject><subject>Tablets</subject><subject>Young Adult</subject><issn>0091-2700</issn><issn>1552-4604</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFUc9v0zAUjhCIlcGdE4rEOezZcZ6TC9JUsV-a1h5AO1qO4y5eU7vYSbf-9zhKqQYS4mJL_n687_lLko8EvhDC-RlARSgHIIQBQQqvkhkpCpoxBPY6mY1wNuInybsQHiMPWUHeJieUIAEK-SzZLVvpN1K5tbG6NyqkbpVe295LK4Ps0rkfQqubdPG8nzvbG5tK20yEnbZuCCOiXOOsTiN452yjtzoetk-XXgflzbY3zqaLrXGmSc_rIWgf3idvVrIL-sPhPk1-XHz7Pr_KbheX1_Pz20whQcyQSYas5oRUNS_LEmvMVU05o6pgucL4ALquGsSqKRsaH4AWjHOUtdKK8Pw0-Tr5bod6oxulx-Cd2HqzkX4vnDTiT8SaVjy4nWAASCqMBp8PBt79HHToxaMbvI2ZBeGAnFBW5pEFE0t5F4LXq-MEAmJsSvzdVJR8epnsKPhdTSSwifDkuj5-2bobnrQXrZZd30Y_ABb9MgqEQkwLGYz9RhkeZKbT-__mEDfz5VVRwBgom4RBPugXW_57gQPfhF4_HwdJvxbIc16I-7tLUSFUF_eIosx_AU8ZylY</recordid><startdate>201204</startdate><enddate>201204</enddate><creator>Lofwall, M. R.</creator><creator>Moody, D. E.</creator><creator>Fang, W. B.</creator><creator>Nuzzo, P. A.</creator><creator>Walsh, S. L.</creator><general>Blackwell Publishing Ltd</general><general>SAGE Publications</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>201204</creationdate><title>Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers</title><author>Lofwall, M. R. ; Moody, D. E. ; Fang, W. B. ; Nuzzo, P. A. ; Walsh, S. L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6166-64a464b7119b78886b63cb2742c543c686b0eb9d669d8d2c680254776abcec173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Administration, Intranasal</topic><topic>Adult</topic><topic>Biological Availability</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Humans</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Narcotics - administration &amp; dosage</topic><topic>Narcotics - pharmacokinetics</topic><topic>Opioid-Related Disorders - epidemiology</topic><topic>Oxycodone - administration &amp; dosage</topic><topic>Oxycodone - pharmacokinetics</topic><topic>Tablets</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lofwall, M. R.</creatorcontrib><creatorcontrib>Moody, D. E.</creatorcontrib><creatorcontrib>Fang, W. B.</creatorcontrib><creatorcontrib>Nuzzo, P. A.</creatorcontrib><creatorcontrib>Walsh, S. L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lofwall, M. R.</au><au>Moody, D. E.</au><au>Fang, W. B.</au><au>Nuzzo, P. A.</au><au>Walsh, S. L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers</atitle><jtitle>Journal of clinical pharmacology</jtitle><addtitle>J Clin Pharmacol</addtitle><date>2012-04</date><risdate>2012</risdate><volume>52</volume><issue>4</issue><spage>600</spage><epage>606</epage><pages>600-606</pages><issn>0091-2700</issn><eissn>1552-4604</eissn><notes>ArticleID:JCPH5500</notes><notes>istex:4B579E42DE558A29DB014ED38B4017F8710C2800</notes><notes>ark:/67375/WNG-9609FW66-8</notes><notes>http:jcp.sagepub.comsupplemental</notes><notes>.</notes><notes>Supplementary data for this article are available at</notes><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21610203</pmid><doi>10.1177/0091270011401620</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-2700
ispartof Journal of clinical pharmacology, 2012-04, Vol.52 (4), p.600-606
issn 0091-2700
1552-4604
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4006196
source Wiley
subjects Administration, Intranasal
Adult
Biological Availability
Double-Blind Method
Female
Humans
Injections, Intravenous
Male
Narcotics - administration & dosage
Narcotics - pharmacokinetics
Opioid-Related Disorders - epidemiology
Oxycodone - administration & dosage
Oxycodone - pharmacokinetics
Tablets
Young Adult
title Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T05%3A31%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20of%20Intranasal%20Crushed%20OxyContin%20and%20Intravenous%20Oxycodone%20in%20Nondependent%20Prescription%20Opioid%20Abusers&rft.jtitle=Journal%20of%20clinical%20pharmacology&rft.au=Lofwall,%20M.%20R.&rft.date=2012-04&rft.volume=52&rft.issue=4&rft.spage=600&rft.epage=606&rft.pages=600-606&rft.issn=0091-2700&rft.eissn=1552-4604&rft_id=info:doi/10.1177/0091270011401620&rft_dat=%3Cproquest_pubme%3E3787323661%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6166-64a464b7119b78886b63cb2742c543c686b0eb9d669d8d2c680254776abcec173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1706712483&rft_id=info:pmid/21610203&rft_sage_id=10.1177_0091270011401620&rfr_iscdi=true